The Radiological Society of North America (RSNA) is launching a new RSNA Global Learning Centers (GLC) program beginning in 2020. By partnering with established radiology departments based in low- or middle-income countries to create the learning centers, RSNA aims to improve radiology education and patient care around the world.

A team of Johns Hopkins data researchers is studying the economic and safety implications associated with the devices used to perform colonoscopies as a disposable version inches closer to widespread availability.

A personalized approach to cancer treatment has become more common over the last several decades, with numerous targeted drugs approved to treat particular tumor types with specific mutations or patterns. However, this same personalized strategy has not translated to radiation therapy, and a one-size-fits-all approach for most patients is still common practice. Moffitt Cancer Center researchers hope to change this mindset for radiation treatment with the development of a genomically-based model that can optimize and personalize a radiation dose to match an individual patient’s needs.

Exo Imaging Inc. announced a $35 million Series B financing round for its high-performance ultrasound platform based on piezoelectric micromachined ultrasonic transducers (pMUT) and artificial intelligence (AI) for imaging and therapeutic applications.

Heidelberg University Hospital, Germany, has started using the RayStation treatment planning system for carbon ion therapy treatments. The center is now using RayStation for both particle therapy and photon therapy.

Philips announced that Taipei Veterans General Hospital (TPVGH) will utilize the Philips IntelliSite Pathology Solution to transform its pathology tissue examination to digital diagnostics. By allowing tissue samples to be remotely viewed within a virtual pathology network across hospital locations, the Philips IntelliSite Pathology Solution will help TPVGH to establish Taiwan’s first fully digitalized pathology department, with the aim of enhancing patient safety and improving the quality of diagnoses, thereby leading to better patient outcomes.

Glassbeam Inc. revealed several technology enhancements in its Rules & Alerts engine that make it dramatically easier and faster for users in large organizations to create and maintain rule-based notifications. This new functionality now comes bundled with machine learning algorithms for triggering alerts based on anomalous values on various types of medical imaging system sensor and log data. Combined with several other features, the new functionality enhances the rules lifecycle management across hundreds of users inside a large enterprise environment where they can create, test and launch new business rules on incoming machine data from thousands of connected assets.

Aided by a high-powered brain scanner and a 3-D printer, National Institutes of Health (NIH) researchers peered inside the brains of hundreds of multiple sclerosis patients. The researchers found that dark rimmed spots representing ongoing, “smoldering” inflammation, called chronic active lesions, may be a hallmark of more aggressive and disabling forms of the disease.

As fiducial markers gain traction in parallel to rising incidences of various cancer affecting lung, prostate, abdomen and kidney, the growth potential of the fiducial markers market is set to witness a considerable rise. Total worldwide sales are anticipated to surpass $100 million by the end of 2019, according to a new study by Fact.MR, registering a significant upswing from $93.9 million in 2018.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now